0 item $0.00

Professor David Ascher

B.Biotech | B.Sci(Hon) | LLB | PhD | MRACI CChem

David Ascher is Head of the Computational Biology and Clinical Informatics laboratory at the Baker Institute, Deputy Director of Biotechnology at The University of Queensland, and Head of Systems and Computational Biology at Bio21 Institute. He is an Associate Editor of PBMB and Frontiers in Bioinformatics and Guest Editor at PLOS Genetics, and holds honorary positions at Cambridge University, FIOCRUZ, and the Tuscany University Network.

David’s research focus is in modelling biological data to gain insight into fundamental biological processes. One of his primary research interests has been developing tools to unravel the link between genotype and phenotype, using computational and experimental approaches to understand the effects of mutations on protein structure and function. His group has developed a platform of 40 widely used programs for assessing the molecular consequences of coding variants (>650,000 hits per month).

Working with clinical collaborators in Australia, Brazil and UK, these methods have been translated into the clinic to guide the diagnosis, management and treatment of a number of hereditary diseases, rare cancers and drug resistant infections.


  • Anders Young Investigator Award (2017)
  • Dr Álvaro Romanha Award (2017)
  • Jack Brockhoff Early Career Researcher Award (2016)
  • Dr Antoniana Ursine Krettli Award (2016)
  • Dr Naftale Katz Award (2015)
  • TJ Martin Award (2014)
  • Bionomics Best Thesis Award (2014)


  • NHMRC Investigator (2020–2024)
  • MDHS Research Fellow (2019)
  • NHMRC CJ Martin Fellow (2014–2018)
  • Victoria Fellow (2013)
  • Churchill Memorial Trust Fellow (2013)

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more